Cresco Labs (CRLBF) Current Assets (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Current Assets came in at $246.7 million in Q1 2026, down 20.71% YoY from $311.1 million in Q1 2025, and down 4.86% on a QoQ basis from $259.3 million in Q4 2025.
Cresco Labs (CRLBF) Current Assets (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Current Assets data on file, last reported at $246.7 million in Q1 2026.
- Quarterly Current Assets fell 20.71% year-over-year to $246.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.7 million (down 20.71% YoY) and the FY2025 annual result came in at $259.3 million, down 11.89% from the prior year.
- Current Assets eased to $246.7 million in Q1 2026, from $259.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $399.8 million in Q1 2022 to a low of $242.6 million in Q3 2025.
- A 5-year average of $298.1 million and a median of $294.3 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets slipped 28.38% — and 2025, when it increased 15.08%.
- Tracing CRLBF's Current Assets over 5 years: stood at $326.0 million in 2022, then retreated by 14.71% to $278.1 million in 2023, then rose by 5.81% to $294.3 million in 2024, then declined by 11.89% to $259.3 million in 2025, then slipped by 4.86% to $246.7 million in 2026.
- The last three Current Assets figures came in at $246.7 million (Q1 2026), $259.3 million (Q4 2025), and $242.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 245.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246.67 Mn |
| Dec 31, 2025 | 259.27 Mn |
| Sep 30, 2025 | 242.64 Mn |
| Jun 30, 2025 | 314.61 Mn |
| Mar 31, 2025 | 311.09 Mn |
| Dec 31, 2024 | 294.26 Mn |
| Sep 30, 2024 | 311.92 Mn |
| Jun 30, 2024 | 273.37 Mn |
| Mar 31, 2024 | 285.08 Mn |
| Dec 31, 2023 | 278.09 Mn |
| Sep 30, 2023 | 303.17 Mn |
| Jun 30, 2023 | 265.24 Mn |
| Mar 31, 2023 | 286.32 Mn |
| Dec 31, 2022 | 326.05 Mn |
| Sep 30, 2022 | 355.20 Mn |
| Jun 30, 2022 | 314.32 Mn |
| Mar 31, 2022 | 399.80 Mn |
| Dec 31, 2021 | 421.76 Mn |
| Sep 30, 2021 | 449.05 Mn |
| Mar 31, 2021 | 381.69 Mn |